Drug recall · September 6, 2023
Sabril (vigabatrin) for Oral Solution recall
Why: Cross contamination with other products
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Sabril (vigabatrin) for Oral Solution, 500 mg, 50 Packets, Rx only, Manufactured by: Patheon, Cincinnati, OH 45237, NDC 67386-211-65
- Lots / codes
Lot#: 3207333A, 3207334A, Exp 03/2027; 3214707A, 3214709A, 3214710A, Exp 02/2028 .
- Quantity
- 10,543 cartons
- Company
- Lundbeck LLC, Deerfield, IL
- Distribution
- Nationwide within the U.S.
- Initiated
- August 17, 2023 · Voluntary: Firm initiated
- Classified
- August 29, 2023
- Reported
- September 6, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Vigabatrin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.